Paper8429263
Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.
Dejager S and 2 others. J Lipid Res, 1993. Cited by 203 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. Papers, record 8429263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8429263
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipoproteins, LDL | Major topic |
| Adult | |
| Centrifugation, Density Gradient | |
| Chemical Phenomena | |
| Chemistry, Physical | |
| Humans | |
| Hyperlipidemia, Familial Combined | |
| Lipid Peroxides | |
| Lipoprotein(a) | |
| Male | |
| Middle Aged | |
| Oxidation-Reduction | |
| Particle Size | |
| Vitamin E |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01384058 | Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes | Background |
Source ClinicalTrials.gov
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42189392 | Desialylated vs. Oxidized LDL: Sialidase Inhibitors as Promising Antiatherosclerotic Agents. | Curr Atheroscler Rep | 2026 | https://conductscience.org/library/papers/42189392 | PubMed |
| 41210345 | LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41210345 | PubMed |
| 40583516 | The Link between Lipids and Inflammation: Focus on Targeting Sialidase Activity as a Novel Strategy for Anti-Atherosclerotic Therapy. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/40583516 | PubMed |
| 38750162 | Effects of phytosterol supplementation on lipoprotein subfractions and LDL particle quality. | Sci Rep | 2024 | https://conductscience.org/library/papers/38750162 | PubMed |
| 38494931 | We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/38494931 | PubMed |
| 37812346 | Should We "RESPECT EPA" More Now? EPA and DHA for Cardiovascular Risk Reduction. | Curr Cardiol Rep | 2023 | https://conductscience.org/library/papers/37812346 | PubMed |
| 34362390 | The effects of fat consumption on low-density lipoprotein particle size in healthy individuals: a narrative review. | Lipids Health Dis | 2021 | https://conductscience.org/library/papers/34362390 | PubMed |
| 32245386 | Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study. | Cardiovasc Diabetol | 2020 | https://conductscience.org/library/papers/32245386 | PubMed |
| 30283212 | High Hydrostatic Pressure Induces a Lipid Phase Transition and Molecular Rearrangements in Low-Density Lipoprotein Nanoparticles. | Part Part Syst Charact | 2018 | https://conductscience.org/library/papers/30283212 | PubMed |
| 28797250 | Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review. | Lipids Health Dis | 2017 | https://conductscience.org/library/papers/28797250 | PubMed |
| 28382948 | High hydrostatic pressure specifically affects molecular dynamics and shape of low-density lipoprotein particles. | Sci Rep | 2017 | https://conductscience.org/library/papers/28382948 | PubMed |
| 25849089 | Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease. | PLoS One | 2015 | https://conductscience.org/library/papers/25849089 | PubMed |
| 24683220 | Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study. | Curr Ther Res Clin Exp | 2009 | https://conductscience.org/library/papers/24683220 | PubMed |
| 24558110 | Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. | Arterioscler Thromb Vasc Biol | 2014 | https://conductscience.org/library/papers/24558110 | PubMed |
| 24264394 | An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes. | Diabetes | 2013 | https://conductscience.org/library/papers/24264394 | PubMed |
| 20574778 | Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk. | Lipids | 2010 | https://conductscience.org/library/papers/20574778 | PubMed |
| 20421882 | Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. | Nat Rev Endocrinol | 2010 | https://conductscience.org/library/papers/20421882 | PubMed |
| 18797861 | Molecular structure of low density lipoprotein: current status and future challenges. | Eur Biophys J | 2009 | https://conductscience.org/library/papers/18797861 | PubMed |
| 17045077 | Alterations in lipoprotein defense against oxidative stress in metabolic syndrome. | Curr Atheroscler Rep | 2006 | https://conductscience.org/library/papers/17045077 | PubMed |
| 16943850 | Dietary polyunsaturated fat intake is associated with low-density lipoprotein size, but not with susceptibility to oxidation in subjects with impaired glucose metabolism and type II diabetes: the Hoorn study. | Eur J Clin Nutr | 2007 | https://conductscience.org/library/papers/16943850 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APOB | 338 | PubTator's text mining | https://conductscience.org/library/genes/338 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8429263
GET https://conductscience.org/api/papers/v1/8429263/cited_by?page=2